10x Genomics
TXG
$14.00
Share price
-4.37%
Change (1 day)
-31.07%
Change (1 year)
Categories
10x Genomics (TXG) - Net assets
Net assets on the balance sheet as of March 2025 : $0.70 Billion USD
According to 10x Genomics
's latest financial reports the company has $0.70 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
10x Genomics - Net assets on balance sheet (from 2018 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$0.71 B | -4.17% |
| 2023-12-31 | $$0.74 B | -8.03% |
| 2022-12-31 | $$0.80 B | -1.45% |
| 2021-12-31 | $$0.81 B | 10.62% |
| 2020-12-31 | $$0.73 B | 75.93% |
| 2019-12-31 | $$0.42 B | -290.96% |
| 2018-12-31 | $-$0.22 Billion | 95.53% |
| 2017-12-31 | $-$0.12 Billion |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | $0.36 B | -48.80% | Jersey |
 Novavax NVAX | -$75.65 Million | -110.70% | 🇺🇸 USA |
 Organovo ONVO | $10.49 M | -98.52% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -88.65% | 🇬🇧 UK |